Dr. Anupama Upadya, MD

Dr. Upadya practices at Center for Sleep and Lung Disorders Inc in Lady Lake, Florida.

Dr. Upadya's NPI, 1922067834, was assigned on March 20, 2006. Dr. Upadya graduated from Lokmanya Tilak Municipal Medical College in 1996. Dr. Upadya holds Florida license 97830.

Dr. Upadya's primary practice is Center for Sleep and Lung Disorders Inc, at 753 Hwy 466, Lady Lake, FL 32159 in Lake County. The practice phone is (352) 391-5500.

Dr. Upadya's primary practice is Center for Sleep and Lung Disorders Inc in Lady Lake, Florida. Dmand AI also links Dr. Upadya to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Upadya practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Upadya's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Upadya is board certified in pulmonary disease by the American Board of Internal Medicine. Dmand AI has Dr. Upadya's licenses on file in 3 states: Florida, California and Connecticut.

Dmand AI lists acute sinusitis, asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic sinusitis, hypersomnia and pleural effusion among the conditions Dr. Upadya treats.

CMS data shows 3,569 Medicare services from Dr. Upadya across 10 procedure codes in 2024, for 909 Medicare patients. Medicare paid $304,739 for them. Every service was in an office.

CMS counts 909 Medicare patients who saw Dr. Upadya in 2024. The largest group is 75 to 84, with 517 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Upadya's median patient age at 78, with 47% women.

In 2024, Dr. Upadya wrote 1,057 Medicare Part D claims for 296 patients. 38% of them were for generic drugs. CMS names the drug for 916 of them, across 24 drugs with 11 or more claims each, at $562,650 in total drug cost. In 2023, CMS named 861 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Upadya for performance year 2024, reported individually. Dr. Upadya accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Upadya as offering telehealth.

Dmand AI links 9 papers to Dr. Upadya, published from 2002 to 2005. The most frequent topics are Critical Illness, Length of Stay and APACHE. Dr. Upadya's most frequent co-author is Adil Salam, MD.

CMS Open Payments shows 212 general payments to Dr. Upadya from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. GlaxoSmithKline, LLC. paid the most, $618.

Dr. Upadya graduated from Lokmanya Tilak Municipal Medical College in 1996.

Dr. Upadya is in network with 8 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.